Vascarta Inc., a clinical-stage biopharmaceutical company advancing innovative treatments for pain and inflammation, announced today the successful completion of the sublingual arm of its Phase I ...

Please provide your email address to receive an email when new articles are posted on . Researchers confirmed that epinephrine can reach therapeutic plasma concentrations via sublingual administration ...

Cynapsus Therapeutics' sublingually delivered reformulation of the drug used to treat advanced Parkinson's disease cleared an initial clinical hurdle, the company said April 24. The medication would ...